The DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.
Osteoprotegerin Deficiency and Juvenile Paget's Disease
Open accessAbstract
BACKGROUND: Juvenile Paget's disease, an autosomal recessive osteopathy, is characterized by rapidly remodeling woven bone, osteopenia, fractures, and progressive skeletal deformity. The molecular basis is not known. Osteoprotegerin deficiency could explain juvenile Paget's disease because osteoprotegerin suppresses bone turnover by functioning as a decoy receptor for osteoclast differentiation factor (also called RANK ligand). METHODS: We evaluated two apparently unrelated Navajo patients with juvenile Paget's disease for defects in the gene encoding osteoprotegerin (TNFRSF11B) using polymerase-chain-reaction (PCR) amplification followed by direct sequencing and Southern blotting of genomic DNA. Genetic markers near TNFRSF11B were evaluated by both a PCR method that involved sequence-tagged site-content mapping of a deletion of TNFRSF11B and PCR spanning the DNA break points. RESULTS: Both patients had a homozygous deletion of TNFRSF11B, with identical break points, on chromosome 8q24.2. The defect spans approximately 100 kb, but neighboring genes are intact. We found that serum levels of osteoprotegerin and soluble osteoclast differentiation factor were undetectable and markedly increased, respectively. CONCLUSIONS: Juvenile Paget's disease can result from osteoprotegerin deficiency caused by homozygous deletion of TNFRSF11B.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation.
Lacey, D. L., Timms, E., Tan, H.-L., Kelley, M. J., Dunstan, C. R., Burgess, T., Elliott, R., Colombero, A., Elliott, G., Scully, S., et al. (1998) · Cell · doi:10.1016/s0092-8674(00)81569-x · Cited by 5,439
Osteoprotegerin-deficient mice develop early onset osteoporosis and arterial calcification.
Bucay, N., Sarosi, I., Dunstan, C. R., Morony, S., Tarpley, J., Capparelli, C., Scully, S., Tan, H. L., Xu, W., Lacey, D. L., et al. (1998) · Genes & Development · doi:10.1101/gad.12.9.1260 · Cited by 2,483
Minireview: The OPG/RANKL/RANK System
Khosla, S. (2001) · Endocrinology · doi:10.1210/endo.142.12.8536 · Cited by 1,515
Severe osteoporosis in mice lacking osteoclastogenesis inhibitory factor/osteoprotegerin.
Mizuno, A., Amizuka, N., Irie, K., Murakami, A., Fujise, N., Kanno, T., Sato, Y., Nakagawa, N., Yasuda, H., Mochizuki, S.-I., et al. (1998) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1998.8697 · Cited by 775
McKusick, V. (1998) · Johns Hopkins University Press eBooks · doi:10.56021/9780801857423 · Cited by 764
Mendelian Inheritance in Man: A Catalog of Human Genes and Genetic Disorders
McKusick, V. A. (1998) · DigitalGeorgetown (Georgetown University Library) · Cited by 681
Role of receptor activator of nuclear factor-κB ligand and osteoprotegerin in bone cell biology
Hofbauer, L. C., & Heufelder, A. E. (2001) · Journal of Molecular Medicine · doi:10.1007/s001090100226 · Cited by 586
The effect of a single dose of osteoprotegerin in postmenopausal women.
Bekker, P. J., Holloway, D., Nakanishi, A., Arrighi, M., Leese, P. T., & Dunstan, C. R. (2001) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2001.16.2.348 · Cited by 484
Mutations in TNFRSF11A, affecting the signal peptide of RANK, cause familial expansile osteolysis
Hughes, A. E., Ralston, S. H., Marken, J., Bell, C., MacPherson, H., Wallace, R. G. H., van Hul, W., Whyte, M. P., Nakatsuka, K., Hovy, L., et al. (2000) · Nature Genetics · doi:10.1038/71667 · Cited by 481
Self-citationCollins, D. (1956) · The Lancet · doi:10.1016/s0140-6736(56)90422-6 · Cited by 469
Pathophysiology and Treatment of Paget's Disease of Bone
Kanis, J. А. (1991) · Medical Entomology and Zoology · Cited by 308
Arterial calcification: A review of mechanisms, animal models, and the prospects for therapy
Wallin, R., Wajih, N., Greenwood, G. T., & Sane, D. C. (2001) · Medicinal Research Reviews · doi:10.1002/med.1010 · Cited by 235
Hofbauer, L. C., Neubauer, A., & Heufelder, A. E. (2001) · Cancer · doi:10.1002/1097-0142(20010801)92:3<460::aid-cncr1344>3.0.co;2-d · Cited by 192
Whyte, M. P., & Hughes, A. E. (2002) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2002.17.1.26 · Cited by 180
Self-citationRecent advances in multifactorial regulation of vascular calcification
Tintut, Y., & Demer, L. L. (2001) · Current Opinion in Lipidology · doi:10.1097/00041433-200110000-00012 · Cited by 142
Evaluation of the role of RANK and OPG genes in Paget’s disease of bone
Wuyts, W. A., Wesenbeeck, L. V., Morales-Piga, A. A., Ralston, S. H., Hocking, L. J., Vanhoenacker, F. M. H. M., Westhovens, R., Verbruggen, L., Anderson, D. M., Hughes, A., et al. (2001) · Bone · doi:10.1016/s8756-3282(00)00411-7 · Cited by 117
Morinaga, T., Nakagawa, N., Yasuda, H., Tsuda, E., & Higashio, K. (1998) · European Journal of Biochemistry · doi:10.1046/j.1432-1327.1998.2540685.x · Cited by 111
Linkage of Paget Disease of Bone to a Novel Region on Human Chromosome 18q23
Good, D. M., Busfield, F., Fletcher, B. H., Duffy, D. L., Kesting, J. B., Andersen, J., & Shaw, J. T. E. (2002) · The American Journal of Human Genetics · doi:10.1086/338658 · Cited by 86
Expansile Skeletal Hyperphosphatasia: A New Familial Metabolic Bone Disease
Whyte, M. P., Mills, B. G., Reinus, W. R., Podgornik, M. N., Roodman, G. D., Gannon, F. H., Eddy, M. C., & McAlister, W. H. (2000) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2000.15.12.2330 · Cited by 75
Self-citationThompson, R. C., Gaull, G. E., Horwitz, S. J., & Schenk, R. (1969) · The American Journal of Medicine · doi:10.1016/0002-9343(69)90147-8 · Cited by 68
Chronic Idiopathic Hyperphosphatasia Associated with Pseudoxanthoma Elasticum
Mitsudo, S. M. (1971) · Journal of Bone and Joint Surgery · doi:10.2106/00004623-197153020-00010 · Cited by 58
Silve, C., Grosse, B., Tau, C., Garabédian, M., Fritsch, J., Delmas, P. D., Cournot, G., & BALSAN, S. (1986) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-62-3-583 · Cited by 56
Juvenile paget disease: Life-long features of a mildly affected young woman
Golob, D. S., McAlister, W. H., Mills, B. G., Fedde, K. N., Reinus, W. R., Teitelbaum, S. L., Beeki, S., & Whyte, M. P. (1996) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.5650110118 · Cited by 53
Self-citationLories, R. J. U., & Luyten, F. P. (2001) · Clinical Rheumatology · doi:10.1007/s100670170095 · Cited by 43
Dunn, V., Condon, V. R., & Rallison, M. L. (1979) · American Journal of Roentgenology · doi:10.2214/ajr.132.4.541 · Cited by 37
Familial idiopathic hyperphosphatasia (FIH): Response to long-term treatment with pamidronate (APD)
Cassinelli, H., Mautalén, C., Heinrich, J. J., Miglietta, A., & Bergadá, C. (1992) · Bone and Mineral · doi:10.1016/0169-6009(92)90924-3 · Cited by 37
Caffey, J. (1972) · PubMed · Cited by 36
Hereditary hyperphosphatasia: 20 year follow-up and response to disodium etidronate
Singer, F., Siris, E. S., Shane, E. J., Dempster, D. W., Lindsay, R., & Parisien, M. V. (1994) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.5650090519 · Cited by 21
Loughery, J., & Gilpin, L. (1989) · Woman s Art Journal · doi:10.2307/1358222 · Cited by 11
Cited by
Osteoclast differentiation and activation
Boyle, W. J., Simonet, W. S., & Lacey, D. L. (2003) · Nature · doi:10.1038/nature01658 · Cited by 6,670
Functions of RANKL/RANK/OPG in bone modeling and remodeling
Boyce, B. F., & Xing, L. (2008) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2008.03.018 · Cited by 1,844
Genetic regulation of osteoclast development and function
Teitelbaum, S. L., & Ross, F. P. (2003) · Nature Reviews Genetics · doi:10.1038/nrg1122 · Cited by 1,701
Matrix-embedded cells control osteoclast formation
Xiong, J., Onal, M., Jilka, R. L., Weinstein, R. S., Manolagas, S. C., & O'Brien, C. A. (2011) · Nature Medicine · doi:10.1038/nm.2448 · Cited by 1,304
RANKL–RANK signaling in osteoclastogenesis and bone disease
Wada, T., Nakashima, T., Hiroshi, N., & Penninger, J. M. (2006) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2005.11.007 · Cited by 1,212
Metadata
- Authors
- Whyte, M. P., Obrecht, S. E., Finnegan, P. M., Jones, J. L., Podgornik, M. N., McAlister, W. H., & Mumm, S.
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2002-07-18
- Volume
- 347
- Issue
- 3
- Pages
- 175-184
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W1999985403
- Cited by
- 445
- References
- 29
- FWCI
- 8.96
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.